TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Halodoc raises $80m in series C funding to focus on vaccine rollout
After piloting vaccination drive-thru clinics with the government in Jakarta and Bali earlier this year, the telemedicine start-up says it will use the new funds to help coordinate the vaccine rollout.
Change Size
Halodoc CEO and cofounder Jonathan Sudharta (Courtesy of Halodoc)
Halodoc has secured US$80 million in its series C funding round to expand its operations and focus on vaccine coordination.
The leading homegrown health tech start-up said on Wednesday that it would use the funds to upgrade the platform and expand market reach in several healthcare businesses. Halodoc’s three main service lines are drug delivery services, virtual consultations and patient appointment bookings.
Led by Indonesian automotive giant Astra International, participants of the series C funding also included Singapore’s Temasek, Denmark’s Novo Holdings, the United States’ Acrew Diversify Capital Fund and Thailand’s Bangkok Bank.
“Halodoc has emerged as the leading health tech provider these past five years. We are very proud to be on the front lines of the fight against the COVID-19 pandemic,” said Halodoc chief executive Jonathan Sudharta in a statement on Wednesday.
The telemedicine company received a strong boost to its business this year when it partnered with the Health Ministry to coordinate the national vaccination drive in certain regions.
It also partnered with on-demand services superapp Gojek to open the first drive-thru vaccination service for the elderly in Jakarta. Halodoc currently operates seven COVID-19 vaccine drive-thru clinics and claims it has vaccinated 80,000 citizens.
“Halococ's appointment booking technology, which was created before the pandemic, has become very useful in helping users to get tested and vaccinated for COVID-19 efficiently and safely,” said Jonathan.
